Oncolix, Inc. Deferred Tax Assets, in Process Research and Development

Oncolix, Inc. Deferred Tax Assets, in Process Research and Development

Oncolix, Inc. had Deferred Tax Assets, in Process Research and Development of $323.54 thousand as of 2017-12-31, per its 10-K filed 2018-03-14.

Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross

us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment · last filed 2018-03-14

• 2017-12-31: Deferred Tax Assets, in Process Research and Development $323.54K.
• 2016-12-31: Deferred Tax Assets, in Process Research and Development $689.18K.